LeJeune Puetz Investment Counsel’s AbbVie ABBV Stock Holding History

LeJeune Puetz Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$1.59M	Buy	9,950 +269	+3%	+$41.1K	0.57%	64
2022 Q4	$1.56M	Hold	9,681	–	–	0.58%	63
2022 Q3	$1.3M	Hold	9,681	–	–	0.53%	64
2022 Q2	$1.48M	Hold	9,681	–	–	0.58%	58
2022 Q1	$1.57M	Hold	9,681	–	–	0.55%	65
2021 Q4	$1.31M	Buy	9,681 +150	+2%	+$17.7K	0.44%	77
2021 Q3	$1.03M	Buy	9,531 +2,151	+29%	+$246K	0.37%	84
2021 Q2	$831K	Buy	7,380 +100	+1%	+$11.3K	0.31%	92
2021 Q1	$788K	Hold	7,280	–	–	0.31%	89
2020 Q4	$780K	Buy	7,280 +200	+3%	+$19.2K	0.34%	84
2020 Q3	$620K	Buy	7,080 +200	+3%	+$18.8K	0.3%	86
2020 Q2	$675K	Sell	6,880 -920	-12%	-$81K	0.35%	81
2020 Q1	$594K	Buy	7,800 +5,332	+216%	+$454K	0.35%	84
2019 Q4	$219K	Buy	+2,468	New	+$205K	0.1%	139
2019 Q3	–	Sell	-1,568	Closed	-$114K	–	177
2019 Q2	$114K	Hold	1,568	–	–	0.06%	169
2019 Q1	$126K	Hold	1,568	–	–	0.07%	157
2018 Q4	$145K	Buy	+1,568	New	+$138K	0.09%	147

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

LeJeune Puetz Investment Counsel's ABBV Position: Q1 2023 in Review

LeJeune Puetz Investment Counsel increased its AbbVie (ABBV) stake by 2.8% in Q1 2023, buying an estimated $41.1K and bringing the position to 9,950 shares worth $1.59M. The position accounts for 0.57% of the portfolio, ranked #64.

LeJeune Puetz Investment Counsel first reported a position in ABBV in Q4 2018 and has held it in 17 quarters since. 3,139 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

LeJeune Puetz Investment Counsel held 9,950 shares of AbbVie worth $1.59M as of Q1 2023.
LeJeune Puetz Investment Counsel bought 269 AbbVie shares in Q1 2023, an estimated $41.1K.
AbbVie made up 0.57% of LeJeune Puetz Investment Counsel's portfolio in Q1 2023, its #64 holding.
LeJeune Puetz Investment Counsel first reported a position in AbbVie in Q4 2018 and has held it in 17 quarters since.
3,139 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on LeJeune Puetz Investment Counsel's 13F filing for Q1 2023, filed 3 May 2023.